Heat Biologics raises $25 million in IPO

Cancer company Heat Biologics Inc. (NASDAQ:HTBX) raised $25 million through the sale of 2.5 million shares at $10 in an IPO underwritten by Aegis Capital and Cantor Fitzgerald. The price values Heat Biologics at $60.8 million. Earlier this month, the company said it planned to sell 2.3 million shares at $10-$12. Heat Biologics first proposed its IPO in May. The company's shares are slated to start trading on Wednesday. ...